| Veerappan Subramaniyam, MD | |
|
900 Sanders Rd Ste A, Cumming, GA 30041-5960 | |
| (770) 534-2020 | |
| (770) 534-8025 |
| Full Name | Veerappan Subramaniyam |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 24 Years |
| Location | 900 Sanders Rd Ste A, Cumming, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144360413 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 052516 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northeast Georgia Medical Center, Inc | Gainesville, GA | Hospital |
| Northside Hospital Forsyth | Cumming, GA | Hospital |
| Northeast Georgia Medical Center Lumpkin | Dahlonega, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Georgia Heart Institute Llc | 4183848062 | 102 |
| Northeast Georgia Medical Center, Inc. | 7517953755 | 30 |
News Archive
A study by Jonathan I. Silverberg, M.D., Ph.D., M.P.H., of St. Luke's—Roosevelt Hospital Center, New York, and colleagues suggests children living the in the United States but born outside the U.S. have a lower prevalence of allergic disease that increases after residing in the United States for one decade.
Arrow International has announced a worldwide voluntary recall of its 5800 Series IABs with Super Arrow-Flex Sheath Introducer. This recall is being conducted because of an increase of "stuck in sheath" reports involving the use of the Super Arrow-Flex Sheath with 5800 Series IAB products. When the IAB becomes stuck in sheath, the user is unable to move the IAB catheter forward or backward, potentially causing a delay in critical therapy.
Men are more likely than women to discontinue a medication due to side effects. More and more men are diagnosed with age-related issues like enlarged prostate and men are being prescribed medications that have side effects. These side effects often cause men to say "NO." In the U.S. and Canada, Prostate prescriptions dominate the treatment of enlarged prostate.
Janssen-Cilag International NV today announced that data from a post-hoc analysis of the Phase 3 COU-AA-302 trial showed that ZYTIGA (abiraterone acetate) plus prednisone provided an 11.8 months overall survival (OS) benefit (53.6 months vs 41.8 months; HR = 0.61 [95% CI, 0.43-0.87]; p = 0.0055), compared to an active control of placebo plus prednisone, in men with early and less aggressive chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC).
› Verified 5 days ago
| Entity Name | Northeast Georgia Medical Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720015993 PECOS PAC ID: 7517953755 Enrollment ID: O20040422000903 |
News Archive
A study by Jonathan I. Silverberg, M.D., Ph.D., M.P.H., of St. Luke's—Roosevelt Hospital Center, New York, and colleagues suggests children living the in the United States but born outside the U.S. have a lower prevalence of allergic disease that increases after residing in the United States for one decade.
Arrow International has announced a worldwide voluntary recall of its 5800 Series IABs with Super Arrow-Flex Sheath Introducer. This recall is being conducted because of an increase of "stuck in sheath" reports involving the use of the Super Arrow-Flex Sheath with 5800 Series IAB products. When the IAB becomes stuck in sheath, the user is unable to move the IAB catheter forward or backward, potentially causing a delay in critical therapy.
Men are more likely than women to discontinue a medication due to side effects. More and more men are diagnosed with age-related issues like enlarged prostate and men are being prescribed medications that have side effects. These side effects often cause men to say "NO." In the U.S. and Canada, Prostate prescriptions dominate the treatment of enlarged prostate.
Janssen-Cilag International NV today announced that data from a post-hoc analysis of the Phase 3 COU-AA-302 trial showed that ZYTIGA (abiraterone acetate) plus prednisone provided an 11.8 months overall survival (OS) benefit (53.6 months vs 41.8 months; HR = 0.61 [95% CI, 0.43-0.87]; p = 0.0055), compared to an active control of placebo plus prednisone, in men with early and less aggressive chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC).
› Verified 5 days ago
| Entity Name | Georgia Heart Institute Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477976520 PECOS PAC ID: 4183848062 Enrollment ID: O20140616001425 |
News Archive
A study by Jonathan I. Silverberg, M.D., Ph.D., M.P.H., of St. Luke's—Roosevelt Hospital Center, New York, and colleagues suggests children living the in the United States but born outside the U.S. have a lower prevalence of allergic disease that increases after residing in the United States for one decade.
Arrow International has announced a worldwide voluntary recall of its 5800 Series IABs with Super Arrow-Flex Sheath Introducer. This recall is being conducted because of an increase of "stuck in sheath" reports involving the use of the Super Arrow-Flex Sheath with 5800 Series IAB products. When the IAB becomes stuck in sheath, the user is unable to move the IAB catheter forward or backward, potentially causing a delay in critical therapy.
Men are more likely than women to discontinue a medication due to side effects. More and more men are diagnosed with age-related issues like enlarged prostate and men are being prescribed medications that have side effects. These side effects often cause men to say "NO." In the U.S. and Canada, Prostate prescriptions dominate the treatment of enlarged prostate.
Janssen-Cilag International NV today announced that data from a post-hoc analysis of the Phase 3 COU-AA-302 trial showed that ZYTIGA (abiraterone acetate) plus prednisone provided an 11.8 months overall survival (OS) benefit (53.6 months vs 41.8 months; HR = 0.61 [95% CI, 0.43-0.87]; p = 0.0055), compared to an active control of placebo plus prednisone, in men with early and less aggressive chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Veerappan Subramaniyam, MD Po Box 742616, Atlanta, GA 30374-2616 Ph: (770) 219-8420 | Veerappan Subramaniyam, MD 900 Sanders Rd Ste A, Cumming, GA 30041-5960 Ph: (770) 534-2020 |
News Archive
A study by Jonathan I. Silverberg, M.D., Ph.D., M.P.H., of St. Luke's—Roosevelt Hospital Center, New York, and colleagues suggests children living the in the United States but born outside the U.S. have a lower prevalence of allergic disease that increases after residing in the United States for one decade.
Arrow International has announced a worldwide voluntary recall of its 5800 Series IABs with Super Arrow-Flex Sheath Introducer. This recall is being conducted because of an increase of "stuck in sheath" reports involving the use of the Super Arrow-Flex Sheath with 5800 Series IAB products. When the IAB becomes stuck in sheath, the user is unable to move the IAB catheter forward or backward, potentially causing a delay in critical therapy.
Men are more likely than women to discontinue a medication due to side effects. More and more men are diagnosed with age-related issues like enlarged prostate and men are being prescribed medications that have side effects. These side effects often cause men to say "NO." In the U.S. and Canada, Prostate prescriptions dominate the treatment of enlarged prostate.
Janssen-Cilag International NV today announced that data from a post-hoc analysis of the Phase 3 COU-AA-302 trial showed that ZYTIGA (abiraterone acetate) plus prednisone provided an 11.8 months overall survival (OS) benefit (53.6 months vs 41.8 months; HR = 0.61 [95% CI, 0.43-0.87]; p = 0.0055), compared to an active control of placebo plus prednisone, in men with early and less aggressive chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC).
› Verified 5 days ago
Raghunath R Katragadda, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Northside Forsyth Dr, Cumming, GA 30041 Phone: 770-844-3200 Fax: 404-851-6325 | |
Otto Goyco, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 900 Sanders Rd, Suite B, Cumming, GA 30041 Phone: 770-781-8840 Fax: 770-781-8098 | |
Ludy Lukose, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 407 East Maple Street, Suite 101, Cumming, GA 30040 Phone: 770-888-6697 Fax: 770-888-6698 | |
Dr. Arinze Hector Duru, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Northside Forsyth Dr, Cumming, GA 30041 Phone: 770-844-3200 | |
Dr. Jeffrey Desalvo, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 Northside Forsyth Dr, Cumming, GA 30041 Phone: 770-844-3200 Fax: 404-851-6325 | |
Dr. Fernando R. Alvarez-bognar, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 260 Elm St, Cumming, GA 30040 Phone: 770-887-1668 Fax: 770-781-9937 | |
Dr. Tyler Inchul An, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4150 Deputy Bill Cantrell Memorial Rd, Suite 290, Cumming, GA 30040 Phone: 404-446-0600 Fax: 404-446-0601 |